Rotavirus is a leading cause of severe gastroenteritis and diarrhea globally, and nearly all children have been infected with ...

"The risk of the original rotavirus vaccine was pretty small, and it was still taken off the market out of an abundance of caution once it was identified that there was a concern ...

Since licensure in 2006, the rotavirus vaccines, RV5 (pentavalent bovine-human ... increased risk of intussusception after the first 1 or 2 doses has slowly emerged, with the risk benefit equation ...

Vaccine series completion for rotavirus, DTaP, PCV at 12 months was highest in January 2020 and remained lower in October 2023.

US. They provide convincing evidence to support their conclusion that using the whole genome, rather than previous use of two surface proteins, enhances our understanding of strain-specific vaccine ...

Monitoring the health benefits of rotavirus vaccines in developing countries is important to document the performance of vaccines in these high-burden settings. For rotavirus vaccines to reach ...

Rotavirus vaccine global effectiveness was estimated as 1-OR after comparing the frequency of rotavirus vaccination in patients positive and negative to rotavirus etiology. Rotavirus vaccine ...

Safer and more broadly effective rotavirus vaccines could be achieved if initial investigations 1 into the boosting effect of plant-derived virus-like particles hold up in further trials.

A recent decrease in the incidence of type 1 diabetes in Australian children may be linked to the introduction of a routine vaccine against rotavirus, according to a study published yesterday (January ...

FDA Approves 5-in-1 Vaccine Against Meningococcal DiseaseThe FDA has approved Penmenvy, a new 5-in-1 shot to protect against meningococcal infections or invasive meningococcal disease (IMD ...